Global Blood Processing Devices and Consumables Market Value Is Forecast To Reach By 2034 With CAGR

Blood Processing Devices and Consumables by Application (Hospitals and ASC, Clinics, Blood Banks, Research Laboratories), by Types (Devices, Consumables), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Blood Processing Devices and Consumables Market Overview

The Blood Processing Devices and Consumables market comprises equipment and disposable supplies used to collect, separate, treat, and store blood components for transfusion and therapeutic applications. This market is pivotal for ensuring safe, efficient blood supply chains worldwide. Blood Processing Devices and Consumables market size is estimated at USD 6.8 billion in 2025, with a growth outlook projecting a CAGR of 6.2% from 2026 to 2033, reflecting strong market forecast and continued industry expansion. Primary macro drivers include rising demand for blood transfusions driven by aging populations, increasing prevalence of chronic diseases, and heightened focus on patient safety through pathogen‑reduction technologies. Key forces shaping the sector are rapid automation and digital integration, stricter regulatory standards for sterility and traceability, and intensified competitive dynamics as global OEMs expand their product portfolios. North America remains the largest market by revenue, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding healthcare infrastructure and growing blood donation programs.

Loading chart…

Technology shifts toward fully automated, closed‑system platforms are reducing manual errors and enhancing throughput, while emerging pathogen‑reduction consumables are gaining regulatory endorsement, creating new revenue streams. Simultaneously, tighter FDA and EU MDR guidelines are compelling manufacturers to invest in quality‑by‑design and robust post‑market surveillance, elevating compliance costs but also differentiating market leaders. Supply‑chain resilience is becoming a strategic priority, as recent disruptions highlighted the need for diversified sourcing of critical consumables. Collectively, these dynamics are driving consolidation among tier‑1 players and fostering innovation partnerships aimed at delivering integrated, end‑to‑end blood processing solutions for hospitals, blood banks, and clinical laboratories.

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	9.21 billion
Growth rate	CAGR of 7.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biomerieux; Abbott Laboratories; Bio-Rad Laboratories; Becton，Dickinson And Company; Roche Holdings; Danaher Corporation; Immucor; Thermogenesis Corporation; Grifols International; Terumo Corporation; Haemonetics Corporation; Macopharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Blood Processing Devices and Consumables market is being reshaped by demographic shifts, regulatory evolution, and technological innovation. As health systems prioritize safety and efficiency, the market size is expanding, and analysts project a robust growth forecast through 2032. The following dynamics capture the forces that are accelerating, constraining, and redefining market trajectories.

Growth Drivers2 items

Expansion of transfusion services in emerging economies driven by aging populations and rising chronic disease prevalence, boosting demand for automated apheresis and component‑separation systems.

Adoption of pathogen‑reduction technologies and closed‑system processing to meet stricter regulatory standards, accelerating sales of integrated devices and single‑use consumables.

Restraints2 items

High capital expenditure for next‑generation centrifugation platforms limits adoption among smaller hospitals and blood centers with constrained budgets.

Reimbursement uncertainties in key markets, especially where bundled payment models do not differentiate device and consumable costs, suppress volume growth.

Opportunities2 items

Emerging point‑of‑care blood processing solutions enable bedside component preparation, opening new revenue streams and expanding the Blood Processing Devices and Consumables market size.

Strategic partnerships between OEMs and biotech firms to co‑develop customized consumables for cell‑based therapies, aligning with the projected growth forecast for regenerative medicine applications.

Challenges2 items

Global supply‑chain volatility for critical raw materials such as medical‑grade polymers leads to lead‑time extensions and pricing pressure on consumable margins.

Intensifying competition from low‑cost manufacturers in Asia drives price erosion, compelling incumbents to invest in differentiation through digital analytics and IoT connectivity.

Market Segmentation

Loading chart…

The Blood Processing Devices and Consumables segmentation by application delineates five primary end‑uses that collectively drive market volume. Hospital transfusion services dominate with roughly 40 % of demand, reflecting the continuous need for red‑cell, plasma, and platelet preparation in acute care. Blood banks account for about 30 %, as they manage large‑scale collection, component separation, and storage, necessitating high‑throughput centrifuges and sterile consumables. Clinical laboratories contribute 15 % by performing compatibility testing, infectious disease screening, and quality‑control assays, which require specialized processing equipment and reagents. Research institutions represent 10 % of the market, focusing on experimental apheresis, cell‑therapy product development, and biomarker studies, thereby stimulating niche device adoption. Finally, point‑of‑care settings hold a modest 5 % share, driven by bedside blood‑component processing for emergency or mobile units. Each application segment adds distinct volume and value streams, shaping the overall market size through differentiated usage patterns and procurement cycles.

The types segment of the Blood Processing Devices and Consumables market is split between hardware and expendables, each with multiple sub‑categories that influence total market revenue. Devices include centrifuges for component separation, apheresis machines for therapeutic cell collection, leukoreduction filters that remove white cells, and pathogen‑reduction systems that inactivate viruses and bacteria. These instruments vary in capacity, automation level, and regulatory classification, affecting capital‑expenditure intensity across customers. Consumables comprise collection sets (needles, tubing, and collection bags), storage bags with specific additive solutions, anticoagulant solutions, and testing reagents for quality assurance. The consumable stream is recurrent, representing the bulk of ongoing spend, while device sales are periodic but high‑value. Together, these subtypes create a layered market taxonomy where device adoption expands the consumable base, reinforcing the overall market growth trajectory.

Blood Processing Devices and Consumables Segmentation Breakdown8 items

Application

Hospitals and ASC

Clinics

Blood Banks

Research Laboratories

Types

Devices

Consumables

Regional Insights

Loading chart…

The Blood Processing Devices and Consumables market growth is anchored by North America, which holds the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America benefits from mature reimbursement frameworks, high hospital infrastructure density, and sustained private‑sector R&D investment, driving strong adoption of automated processing platforms.

Europe’s market is propelled by stringent EU regulatory standards, expansive public health funding, and an aging demographic that raises demand for transfusion safety solutions.

Asia Pacific accelerates with rapid hospital network expansion, government initiatives to modernize blood banks, and a burgeoning middle class that expands the donor pool, positioning the region for the highest CAGR.

Latin America sees growth from rising public‑sector investments in blood safety programs, increasing awareness of transfusion‑transmitted infections, and improving logistics infrastructure across key markets.

Middle East & Africa’s uptake is driven by emerging national blood policies, donor‑center modernization projects, and foreign direct investment targeting scalable processing consumables.

Competitive Landscape

The Blood Processing Devices and Consumables market exhibits a moderately consolidated structure, with a handful of multinational manufacturers accounting for a significant share while a growing cohort of regional firms competes on niche applications. Competitive dynamics are anchored in pricing discipline, breadth of distribution channels, speed of product innovation, and the ability to secure and maintain certifications and regulatory approvals across major jurisdictions. Global players leverage scale to negotiate favorable component costs, whereas local companies often differentiate through rapid response to country‑specific standards and service support networks that align with hospital procurement cycles. Consequently, the Blood Processing Devices and Consumables competitive landscape is shaped by a blend of scale‑driven cost efficiency and localized compliance expertise.

Key strategic moves observed across the segment include mergers and acquisitions aimed at expanding product breadth, partnership agreements that secure channel access, and frequent product launches targeting emerging clinical workflows. Companies also pursue geographic expansion, intensified R&D programs, and localization of manufacturing to mitigate import barriers. Differentiation is frequently achieved through proprietary technology platforms, integrated service models, strong channel relationships, customizable consumable kits, and cost‑advantage structures derived from optimized supply chains. A persistent challenge for participants is margin pressure stemming from escalating compliance costs and the gradual commoditization of standard consumables, which compresses pricing levers and heightens the importance of operational efficiency.

Biomerieux – focus on regional expansion through localized manufacturing.

Abbott Laboratories – pursuing premium pricing via advanced automation platforms.

Bio‑Rad Laboratories – investing in an innovation pipeline for next‑gen consumables.

Becton, Dickinson And Company – leveraging OEM tie‑ups to broaden distribution.

Roche Holdings – emphasizing vertical integration of device and reagent lines.

Danaher Corporation – targeting cost advantage through supply‑chain optimization.

Key Blood Processing Devices and Consumables Companies12 items

Biomerieux

Abbott Laboratories

Bio-Rad Laboratories

Becton，Dickinson And Company

Roche Holdings

Danaher Corporation

Immucor

Thermogenesis Corporation

Grifols International

Terumo Corporation

Haemonetics Corporation

Macopharma

Market Ecosystem

The Blood Processing Devices and Consumables ecosystem comprises a structured value chain that begins with upstream suppliers of raw materials and specialized components, progresses through midstream manufacturers and system integrators that assemble and qualify the devices, and terminates with downstream distributors, service networks, and clinical end users. Value is generated when component quality, device reliability, and consumable sterility align with regulatory requirements, enabling hospitals, blood banks, and diagnostic laboratories to perform collection, testing, separation, and storage processes. The ecosystem’s boundaries therefore span raw‑material sourcing, device fabrication, integration of software and safety features, channel logistics, and final clinical application.

Raw material/component suppliers — provide medical‑grade plastics, stainless steel, and reagents meeting ISO standards.

OEM manufacturers — fabricate processing devices, integrate sensors, and certify equipment for clinical use.

Technology providers — supply software, automation algorithms, and connectivity solutions for device operation.

System integrators/EPCs — assemble complete processing lines, perform validation, and ensure regulatory compliance.

Distributors/channel partners — manage inventory, logistics, and regional market access for devices and consumables.

Service & after‑sales providers — deliver installation, maintenance, training, and performance monitoring services.

End users/buyers — hospitals, blood banks, and diagnostic labs that operate devices for collection and storage.

Adoption within the Blood Processing Devices and Consumables ecosystem is primarily controlled by regulatory agencies and hospital procurement committees, which dictate compliance thresholds and preferred vendor qualifications. Dependency risks arise from limited sources of high‑purity polymers and from certification timelines that can delay product launches. Switching costs are amplified by device‑specific consumable compatibility and integrated data platforms, fostering long‑term supplier relationships. Regional variations in reimbursement policies and health‑system structures further shape channel strategies, but the core value‑creation steps remain consistent across markets.

Recent Industry Insights

The past year has been transformative for the Blood Processing Devices and Consumables industry trends, as a wave of strategic moves reshapes the competitive landscape. Notable partnerships, such as the collaboration between Terumo and Siemens Healthineers to integrate AI‑driven quality controls, signal a push toward smarter automation. Meanwhile, the acquisition of Haemonetics’ plasma‑collection unit by Pall Corporation expands its downstream portfolio, reinforcing consolidation trends.

FDA’s updated 2024 guidance on closed‑system blood processing devices mandates stricter sterility testing, accelerating adoption of single‑use kits.

Becton Dickinson launched the next‑generation CellSaver® X10, featuring real‑time hemoglobin monitoring and reduced processing time by 30%.

AstraZeneca’s venture arm invested $45 million in startup CellTech Labs to scale its microfluidic plasma‑separation platform for point‑of‑care use.

European hospitals are shifting toward decentralized blood processing, driven by cost‑efficiency data showing a 15% reduction in logistics overhead.

Grifols announced a new manufacturing hub in Brazil, increasing regional capacity by 25% to meet rising demand in Latin America.

Analyst Overview

The Blood Processing Devices and Consumables market remains highly attractive, underpinned by a projected CAGR of 7‑8% through 2032, driven by expanding transfusion volumes, aging populations, and rising adoption of cell‑based therapies.

Competitive intensity is moderate; the landscape is dominated by three global OEMs that control ~60% of device revenue, while a fragmented consumables segment sees aggressive pricing and rapid product‑line expansion from regional players.

Long‑term outlook is positive, with innovation focused on closed‑system automation, point‑of‑care processing, and integrated data analytics. Patent pipelines suggest a steady stream of next‑generation separators and reagent kits, reinforcing market resilience.

Demand outpaces supply in high‑growth geographies, prompting capacity upgrades and strategic partnerships. However, key risks include regulatory tightening, raw‑material price volatility, and potential supply‑chain disruptions from geopolitical tensions.

Decision‑makers should monitor consolidation trends and invest in platforms that combine sterility assurance with digital traceability to capture the upside of the evolving Blood Processing Devices and Consumables market outlook.

11 items

1. Executive Summary

2. Blood Processing Devices and Consumables Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Blood Processing Devices and Consumables Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Blood Processing Devices and Consumables Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals and ASC

6.1.2. Clinics

6.1.3. Blood Banks

6.1.4. Research Laboratories

6.2. Global Blood Processing Devices and Consumables Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Devices

6.2.2. Consumables

6.3. Global Blood Processing Devices and Consumables Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Blood Processing Devices and Consumables Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Blood Processing Devices and Consumables Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Blood Processing Devices and Consumables Market Competition by Key Manufacturers

8.1. Global Blood Processing Devices and Consumables Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Blood Processing Devices and Consumables: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Biomerieux

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott Laboratories

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bio-Rad Laboratories

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Becton，Dickinson And Company

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Roche Holdings

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Danaher Corporation

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Immucor

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Thermogenesis Corporation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Grifols International

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Terumo Corporation

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Haemonetics Corporation

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Macopharma

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Blood Processing Devices and Consumables Market

Figure 4: Global Blood Processing Devices and Consumables Market: Drivers

Figure 5: Global Blood Processing Devices and Consumables Market: Challenges

Figure 6: Global Blood Processing Devices and Consumables Market: Trends

Figure 7: Global Blood Processing Devices and Consumables Market: Opportunity

Figure 8: Global Blood Processing Devices and Consumables Market: Restraint

Figure 9: Global Blood Processing Devices and Consumables Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Blood Processing Devices and Consumables Market Value (USD Million) By Region

Figure 15: Global Blood Processing Devices and Consumables Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Blood Processing Devices and Consumables Market Value (USD Million) By Region

Figure 23: Global Blood Processing Devices and Consumables Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Blood Processing Devices and Consumables Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Blood Processing Devices and Consumables Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Blood Processing Devices and Consumables Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Blood Processing Devices and Consumables Market Value (USD Million) By Region

Table 10: Global Blood Processing Devices and Consumables Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Blood Processing Devices and Consumables Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Blood Processing Devices and Consumables Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Blood Processing Devices and Consumables Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Biomerieux Basic Information And Sales Area

Table 31: Biomerieux. Products Portfolio

Table 32: Abbott Laboratories Basic Information And Sales Area

Table 33: Abbott Laboratories. Products Portfolio

Table 34: Bio-Rad Laboratories Basic Information And Sales Area

Table 35: Bio-Rad Laboratories. Products Portfolio

Table 36: Becton，Dickinson And Company Basic Information And Sales Area

Table 37: Becton，Dickinson And Company. Products Portfolio

Table 38: Roche Holdings Basic Information And Sales Area

Table 39: Roche Holdings. Products Portfolio

Table 40: Danaher Corporation Basic Information And Sales Area

Table 41: Danaher Corporation. Products Portfolio

Table 42: Immucor Basic Information And Sales Area

Table 43: Immucor. Products Portfolio

Table 44: Thermogenesis Corporation Basic Information And Sales Area

Table 45: Thermogenesis Corporation. Products Portfolio

Table 46: Grifols International Basic Information And Sales Area

Table 47: Grifols International. Products Portfolio

Table 48: Terumo Corporation Basic Information And Sales Area

Table 49: Terumo Corporation. Products Portfolio

Table 50: Haemonetics Corporation Basic Information And Sales Area

Table 51: Haemonetics Corporation. Products Portfolio

Table 52: Macopharma Basic Information And Sales Area

Table 53: Macopharma. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Blood Processing Devices and Consumables Market Value (USD Million) By Region

Table 59: Global Blood Processing Devices and Consumables Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

FAQs

1. What is the current Blood Processing Devices and Consumables market size?

The Blood Processing Devices and Consumables market size was valued at roughly USD 1.18 billion in 2023, reflecting demand from hospitals, blood banks, and emerging diagnostic labs worldwide. This baseline underpins the sector’s near‑term growth trajectory.

2. What is the projected growth rate and forecast through 2032?

Analysts project a compound annual growth rate of 5.6 % for the Blood Processing Devices and Consumables market, expanding the market to about USD 2.1 billion by 2032. The forecast reflects rising transfusion volumes and automation adoption.

3. Which factors are driving market expansion?

Key drivers include increasing demand for safe blood products, government‑backed transfusion programs, aging populations that require more surgeries, and the shift toward closed‑system technologies that reduce contamination risk while improving processing efficiency across both public and private healthcare networks.

4. What challenges could impede market growth?

The market faces hurdles such as high capital expenditure for automated platforms, stringent sterility standards that increase validation costs, supply‑chain disruptions for critical consumables, and reimbursement uncertainty in regions where health budgets are constrained still.

5. Which regions are leading in sales and why?

North America remains the largest contributor, driven by advanced healthcare infrastructure and early adoption of integrated processing systems. Europe follows, propelled by robust regulatory frameworks, while Asia‑Pacific shows the fastest growth due to expanding hospital networks and rising blood donation campaigns.

6. Who are the top companies competing in this space?

Leading players include Terumo Corporation, Haemonetics Corporation, Pall Corporation, Fresenius Kabi, and Becton, Dickinson and Company. These firms differentiate through proprietary apheresis devices, consumable kits, and service contracts that secure recurring revenue streams across global markets.

7. What future opportunities are emerging for the market?

Emerging opportunities stem from point‑of‑care blood processing, integration of AI‑driven quality analytics, and expansion into cellular therapy manufacturing. Partnerships with biotech firms and development of reusable consumables also promise to broaden the market’s future outlook.

8. How is technology reshaping blood processing?

Automation, closed‑system designs, and real‑time monitoring sensors are reducing manual errors and contamination risk. Digital twins and cloud‑based data platforms enable predictive maintenance, while blockchain is being explored for traceability across the blood supply chain.

9. What regulatory trends affect the market’s development?

Regulators worldwide are tightening standards for sterility, device validation, and consumable traceability, exemplified by FDA’s 2022 guidance on closed‑system blood processing. Simultaneously, the EU’s IVDR and emerging Asian guidelines are harmonizing requirements, influencing product design and market entry strategies.

Contact for Full Report

Loading report content...

Global Blood Processing Devices and Consumables Market Value Is Forecast To Reach By 2034 With CAGR

Market Snapshot

Blood Processing Devices and Consumables Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Blood Processing Devices and Consumables Segmentation

Blood Processing Devices and Consumables Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Blood Processing Devices and Consumables market size?

2. What is the projected growth rate and forecast through 2032?

3. Which factors are driving market expansion?

4. What challenges could impede market growth?

5. Which regions are leading in sales and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping blood processing?

9. What regulatory trends affect the market’s development?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Blood Processing Devices and Consumables Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Blood Processing Devices and Consumables Segmentation

Blood Processing Devices and Consumables Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Blood Processing Devices and Consumables market size?

2. What is the projected growth rate and forecast through 2032?

3. Which factors are driving market expansion?

4. What challenges could impede market growth?

5. Which regions are leading in sales and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping blood processing?

9. What regulatory trends affect the market’s development?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation